FindTrial
Sign In

A multicenter cohort study on prognosis analysis of patients with advanced lung cancer undergoing immunotherapy based on multimodal information

A multicenter cohort study on prognosis analysis of patients with advanced lung cancer undergoing immunotherapy based on multimodal information

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107289
Enrollment
Unknown
Registered
2025-08-07
Start date
2025-08-08
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced lung cancer

Interventions

control group:None
research group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Confirmed by histology as lung cancer and initially diagnosed at an advanced stage; 2.Disease progression occurs within or after half a year of receiving immunotherapy; 3.Aged between 18 and 80; 4.Those with complete clinical data.

Exclusion criteria

Exclusion criteria: 1.Not having received immunotherapy or only receiving other treatment methods (targeted therapy, chemotherapy, radiotherapy, etc.); 2.Accompanied by other malignant diseases; 3.Lost to follow-up during the follow-up period; 4.Refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Secondary

MeasureTime frame
Progression-free survival;Objective remission rate;Disease control rate;—

Countries

China

Contacts

Public ContactJin Yang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

whuhjy@sina.com+86 29 85755457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026